FORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN BENZOATEFORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN BENZOATE

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 2

Abstract

In situ gel drug delivery systems are in elucidation form prior to supervision but once administered, endure gelation in situ, to form a gel. In the current revise nasal in situ gel of rizatriptan Benzoate was primed for the cure of nasal infections to give sustained release of drug and to attain site specific action. Carbopol was use as a pH triggered polymer Different formulations were prepared by varying the concentrations of Carbopo with Hydroxylpropyl Methylcellulose (HPMC). These formulations were evaluated for parameters like drug excipient compatibility, pH, drug content, gelation temperature, viscosity, in vitro drug release, mucoadhesion, ex vivo permeation and stability studies. FTIR study exposed that there was no interface between drug and polymer. pH of all the formulations were initiate to be in the vary of 5.4-6.2 and the drug substance for all the prepared formulations was initiate to be in the assortment of 94%-99%. The results of in vitro drug release and mucoadhesive strength indicated that the optimized formulation F5 and is the most successful formulations of the study, exhibited a sustained drug release of in 87.7% in 7 hours. mucoadhesive strength of 2024.64 and 3267.76 dyne/cm2. From the results it is fulfilled that rizatriptan Benzoate nasal in situ gel produce extended and site specific drug delivery.

Authors and Affiliations

Piyush Agarwal*| Bhupal Nobels College of Pharmaceutical Sciences, Udaipur, Rajasthan, India, Amit Kumar| Dept of Pharmacy, Jodhpur National University, Jodhpur, Rajasthan, India, Y. S. Tanwar| Bhupal Nobels College of Pharmaceutical Sciences, Udaipur, Rajasthan, India, Shailendra Sharma| Jodhpur Institute of Pharmacy, Jodhpur, Rajasthan, India

Keywords

Related Articles

SERO-PREVALENCE OF HEPATITIS B VIRUS (HBsAg) AND HEPATITIS C VIRUS (Anti-HCV) AMONG HIV-INFECTED IN SUDAN

Background: Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) were three most common chronic viral infections all over the world, they shares similar routes of transmission. Hepatit...

COMPARATIVE IN VITRO ANALYSIS OF PHYSICOCHEMICAL PROPERTIES OF SOME ACECLOFENAC GENERIC TABLETS MARKETED IN BANGLADESH

Aceclofenac is a non-steroidal anti-inflammatory drug analog of diclofenac and works by inhibiting the action of cyclooxygenase (COX) that is involved in the production of prostaglandin (PG) and accountable for pain, swe...

BACTERIOLOGICAL PROFILE OF CHRONIC SUPPURATIVE OTITIS MEDIA IN A TERTIARY CARE CENTRE IN SOUTH INDIA

Background: Chronic suppurative otitis media (CSOM) is a disease of multiple aetiologies and is well known for its persistence despite treatment and may result in permanently disabling and potentially fatal complication...

LIQUID CRYSTALLINE SYSTEM: A NOVEL APPROACH FOR DRUG DELIVERY

Liquid crystaline system is a thermodynamically stable phase which is characterized by anisotropy. LC’s are also termed as mesophase as they exhibit isotropic properties and fluid-like behavior under some conditions (cha...

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF TELMISARTAN IN BULK AND FORMULATION USING FLUORESCENCE DETECTOR.

Asensitive, accurate and precise RP-HPLC method using Fluorescence detector has been developed and validated for the estimation of TELMISARTAN from bulk drug and Pharmaceutical Dosage form. The separation was achieved by...

Download PDF file
  • EP ID EP3833
  • DOI -
  • Views 434
  • Downloads 24

How To Cite

Piyush Agarwal*, Amit Kumar, Y. S. Tanwar, Shailendra Sharma (2017). FORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN BENZOATEFORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN BENZOATE. Journal of Biomedical and Pharmaceutical Research, 6(2), 39-49. https://europub.co.uk/articles/-A-3833